ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

UICC Announces Four Fellowship Program

April 22, 1983

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977